Johnson & Johnson financials
$267.57−1.61%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 28 | FY24 Dec 29 | FY23 Dec 31 | FY22 Jan 1 | FY21 Jan 2 | FY20 Jan 3 | FY19 Dec 29 | FY18 Dec 30 | FY17 Dec 31 | FY16 Jan 1 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $94.19B | $88.82B | $85.16B | $79.99B | $78.74B | $82.58B | $82.06B | $81.58B | $76.45B | $71.89B |
| Gross profit | $63.94B | $61.35B | $58.61B | $55.39B | $55.34B | $54.16B | $54.50B | $54.49B | $51.01B | $50.10B |
| Gross margin | 67.9% | 69.1% | 68.8% | 69.3% | 70.3% | 65.6% | 66.4% | 66.8% | 66.7% | 69.7% |
| Operating income | $25.29B | $20.80B | $21.21B | $19.95B | $19.83B | $19.49B | $19.81B | $19.80B | $18.18B | $20.37B |
| Net income | $26.80B | $14.07B | $35.15B | $17.94B | $20.88B | $14.71B | $15.12B | $15.30B | $1.30B | $16.54B |
| Net margin | 28.5% | 15.8% | 41.3% | 22.4% | 26.5% | 17.8% | 18.4% | 18.8% | 1.7% | 23.0% |
| Diluted EPS | $11.03 | $5.79 | $13.72 | $6.73 | $7.81 | $5.51 | $5.63 | $5.61 | $0.47 | $5.93 |
| EBITDA | $33.02B | $28.38B | $29.18B | $27.20B | $27.43B | $26.96B | $27.09B | $26.98B | $24.13B | $24.62B |
| Operating cash flow | $24.53B | $24.27B | $22.79B | $21.19B | $23.41B | $24.68B | $23.42B | $22.20B | $21.06B | $18.77B |
| Free cash flow | $19.31B | $18.06B | $17.78B | $17.18B | $19.76B | $21.34B | $19.92B | $18.53B | $17.78B | $15.54B |
| Diluted shares | 2,429.4M | 2,429.4M | 2,560.4M | 2,663.9M | 2,674.0M | 2,670.7M | 2,684.3M | 2,728.7M | 2,745.3M | 2,788.9M |
Balance sheet
| Period end | Dec 28 | Dec 29 | Dec 31 | Jan 1 | Jan 2 | Jan 3 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $19.71B | $24.11B | $21.86B | $12.89B | $14.49B | $13.98B |
| Short-term investments | $393.0M | $417.0M | $1.07B | $9.39B | $17.12B | $11.20B |
| Total debt | $47.93B | $36.63B | $29.33B | $39.64B | $33.75B | $35.27B |
| Total assets | $199.21B | $180.10B | $167.56B | $187.38B | $182.02B | $174.89B |
| Total liabilities | $117.67B | $108.61B | $98.78B | $110.57B | $108.00B | $111.62B |
| Shareholders' equity | $81.54B | $71.49B | $68.77B | $76.80B | $74.02B | $63.28B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology